Related references
Note: Only part of the references are listed.Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir
Amy C. Sherman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
Baseline CD4+T-Cell Counts Predict HBV Viral Kinetics to Adefovir Treatment in Lamivudine-Resistant HBV-Infected Patients with or without HIV Infection
K. J. Cortez et al.
HIV CLINICAL TRIALS (2013)
Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus-positive newborns
S. Shrivastava et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Barbara Rehermann
NATURE MEDICINE (2013)
HEPATITIS Long-term therapy of chronic hepatitis B reverses cirrhosis
Anna Suk-Fong Lok
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
New Therapeutic Targets and Drugs for the Treatment of Chronic Hepatitis B
Simon P. Fletcher et al.
SEMINARS IN LIVER DISEASE (2013)
A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice
Pascale Buchmann et al.
VACCINE (2013)
Combination of DNA Prime - Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model
Anna D. Kosinska et al.
PLOS PATHOGENS (2013)
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
Fei Liu et al.
PLOS PATHOGENS (2013)
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
Antonio Bertoletti et al.
GUT (2012)
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines
Adam J. Gehring et al.
JOURNAL OF HEPATOLOGY (2011)
Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells
Vittore Cereda et al.
VACCINE (2011)
Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations
Amanda L. Boehm et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells
Risa K. Benwell et al.
CLINICAL IMMUNOLOGY (2010)
Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options
Maureen M. Jonas et al.
HEPATOLOGY (2010)
The molecular basis of the failed immune response in chronic HBV: Therapeutic implications
Mala K. Maini et al.
JOURNAL OF HEPATOLOGY (2010)
CD8(+) T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions
Sandra Phillips et al.
JOURNAL OF IMMUNOLOGY (2010)
Pathogenesis of hepatitis B virus infection
F. V. Chisari et al.
PATHOLOGIE BIOLOGIE (2010)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen
Cinzia Remondo et al.
VACCINE (2009)
Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses
Elizabeth K. Wansley et al.
CLINICAL CANCER RESEARCH (2008)
Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion
Alexander Evans et al.
HEPATOLOGY (2008)
Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells
Michael B. Bernstein et al.
VACCINE (2008)
Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-Cell responses to pre-S and S regions of the viral envelope protein
Stephan Menne et al.
JOURNAL OF VIROLOGY (2007)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCVNS3 and Core proteins
Aurelia A. Haller et al.
VACCINE (2007)
Cytotoxic CD4+ T cells in viral hepatitis
N. Aslan et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B1
Dongping Xu et al.
JOURNAL OF IMMUNOLOGY (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination
T Bauer et al.
VACCINE (2006)
The immune response during hepatitis B virus infection
Antonio Bertoletti et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Different immunogenicity of H-2Kb-restricted epitopes in natural variants of the hepatitis B surface antigen
R Schirmbeck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Epstein-Barr nuclear antigen 1-specific CD4+ Th1 cells kill Burkitt's lymphoma cells
C Paludan et al.
JOURNAL OF IMMUNOLOGY (2002)
Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen
H Höhn et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Characterization of CD4+ CTLs ex vivo
V Appay et al.
JOURNAL OF IMMUNOLOGY (2002)
Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
AC Stubbs et al.
NATURE MEDICINE (2001)
Share Paper
